Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-introduces-hong-kongs-first-fragile-x-carrier-screening
https://www.med.cuhk.edu.hk/press-releases/cuhk-introduces-hong-kongs-first-fragile-x-carrier-screening

CUHK Introduces Hong Kong's First Fragile X Carrier Screening

Down syndrome and Fragile X syndrome are respectively the first and the second most common causes of congenital mental retardation. As the incidence of newborn Down syndrome has been successfully minimized by the effective prenatal screening and diagnosis, Fragile X syndrome has now become more important, affecting 1 in 4,000 to 10,000 males. The disease is caused by inheriting the abnormal gene from their carrier-mothers. The Department of Obstetrics and Gynaecology at The Chinese University of Hong Kong (CUHK) launches the territory's first Fragile X carrier screening by introducing the new Fragile X PCR technology, which enable doctors to identify women with such hidden genetic problem.

 

Professor Tak Yeung Leung (right 2), Professor; Professor Richard Kwong Wai Choy (right 1), Associate Professor and Prof. Grace Wing Shan Kong (left 1), Assistant Professor, Department of Obstetrics and Gynaecology and Prof. Ellis Kam Lum Hon (left 2), Professor, Department of Paediatrics at CUHK present the strengths of the CUHK's new PCR technology in delivery of faster and more accurate results, and suitable for large-scale screening than Fragile X screening methods such as Southern blot analysis and conventional PCR method.

Professor Tak Yeung Leung (right 2), Professor; Professor Richard Kwong Wai Choy (right 1), Associate Professor and Prof. Grace Wing Shan Kong (left 1), Assistant Professor, Department of Obstetrics and Gynaecology and Prof. Ellis Kam Lum Hon (left 2), Professor, Department of Paediatrics at CUHK present the strengths of the CUHK's new PCR technology in delivery of faster and more accurate results, and suitable for large-scale screening than Fragile X screening methods such as Southern blot analysis and conventional PCR method.

About 1 in 250-1000 females are asymptomatic carriers of the defected (pre-mutation) FMR1 gene located in the X chromosome, in which there is an increased number of unstable CGG trinucleotide repeat (55-200 times). Once this pre-mutation is transmitted to a male baby, there is a significant risk that the repeats will further expand to beyond 200 times (full-mutation), leading to mental disability and autism. Female carriers are also at risk of pre-mature menopause. Therefore, carrier screening may assist prenatal diagnosis of abnormal fetuses as well as assessment of women's health.

The traditional diagnostic method of Fragile X syndrome is Southern blot analysis. Although it is accurate in counting the number of CGG repeats, it is labour intensive and time-consuming and hence not suitable for large-scale screening purpose. The conventional PCR method allows rapid analysis but is incapable of counting repeats more than 130 times, resulting in false negative result.

The Department of Obstetrics and Gynaecology of CUHK is the first to introduce Fragile X PCR, a new PCR method designed specifically for Fragile X mutation screening. Unlike the conventional PCR, it is capable of counting the CGG repeats up to 900 times, and can precisely distinguish normal (<44 repeats), intermediate (45-54 repeats), pre-mutation (55 – 200 repeats) and full mutation (>200 repeats). It is also a high throughput method and can produce results after one day. Recently, CUHK validated this new Fragile X PCR method on 14 full-mutation cases, 20 pre-mutation cases, and 75 normal controls with 100% accuracy.

 

If a pregnant woman is confirmed to be a carrier, prenatal diagnosis can then be performed to check the fetus. CUHK has recently identified an affected male fetus of a carrier-mother using Fragile X PCR which assisted the management of her pregnancy.

In conclusion, CUHK has successfully introduced a new technique —Fragile X PCR for carrier screening. The method overcomes the existing technical difficulties by providing rapid and accurate result. It is suitable for population-based screening as well as prenatal screening and diagnosis of Fragile X syndrome. For appointment or enquiry on the above service, please call 3505 6412.

 

CUHK's Hong Kong's first and new PCR technology is capable of counting CGG repeats up to 900 times, and can precisely distinguish normal (<44 repeats), intermediate (45-54 repeats), pre-mutation (55 – 200 repeats) and full mutation (>200 repeats). It is also a high throughout method and can produce results after one day
CUHK's Hong Kong's first and new PCR technology is capable of counting CGG repeats up to 900 times, and can precisely distinguish normal (<44 repeats), intermediate (45-54 repeats), pre-mutation (55 – 200 repeats) and full mutation (>200 repeats). It is also a high throughout method and can produce results after one day
CUHK's Hong Kong's first and new PCR technology is capable of counting CGG repeats up to 900 times, and can precisely distinguish normal (<44 repeats), intermediate (45-54 repeats), pre-mutation (55 – 200 repeats) and full mutation (>200 repeats). It is also a high throughout method and can produce results after one day

More Press Releases

CUHK-Baylor Study Proves Aspirin Reduces the Risk of Preeclampsia by Decelerating the Metabolic Clock of Gestation

CUHK-Baylor Study Proves Aspirin Reduces the Risk of Preeclampsia by Decelerating the Metabolic Clock of Gestation

Research
CU Medicine Study Shows Recovered Mothers Transfer COVID-19 Antibodies to Newborn Babies

CU Medicine Study Shows Recovered Mothers Transfer COVID-19 Antibodies to Newborn Babies

Research
CUHK Proves Modified HIFU Treatment Effective for Treating Uterine Fibroids

CUHK Proves Modified HIFU Treatment Effective for Treating Uterine Fibroids

Research
CUHK Pioneers Whole Genome Sequencing for Identifying the Chromosomal Abnormalities in Couples with Recurrent Miscarriages

CUHK Pioneers Whole Genome Sequencing for Identifying the Chromosomal Abnormalities in Couples with Recurrent Miscarriages

Research
Chinese Women with Polycystic Ovarian Syndrome have 4-fold Higher Risk of Developing Diabetes

Chinese Women with Polycystic Ovarian Syndrome have 4-fold Higher Risk of Developing Diabetes

Research
CUHK Validates the Enhanced UK Fetal Medicine Foundation’s Triple Test Can Double the Detection Rate of Preterm Preeclampsia in Asian Pregnant Women

CUHK Validates the Enhanced UK Fetal Medicine Foundation’s Triple Test Can Double the Detection Rate of Preterm Preeclampsia in Asian Pregnant Women

Research
CUHK Pioneers Whole Genome Sequencing for Prenatal Diagnosis in Hong Kong

CUHK Pioneers Whole Genome Sequencing for Prenatal Diagnosis in Hong Kong

Research
CUHK Studies Alert Mothers to Pregnancy Weight Gain

CUHK Studies Alert Mothers to Pregnancy Weight Gain

Research
CUHK Recommends Oral Glucose Tolerance Test for All Pregnant Women Study Reveals Children of Women with Gestational Diabetes Mellitus Have 3-Fold Diabetes Risk

CUHK Recommends Oral Glucose Tolerance Test for All Pregnant Women Study Reveals Children of Women with Gestational Diabetes Mellitus Have 3-Fold Diabetes Risk

Research
CUHK Launches World’s First Study on Ovum Ageing and Female Infertility by Using Single-Cell Genomics Technology

CUHK Launches World’s First Study on Ovum Ageing and Female Infertility by Using Single-Cell Genomics Technology

Research
CUHK Launches Newborn Add-on Test for Congenital Adrenal Hyperplasia Supported by Joshua Hellmann Foundation for Orphan Disease

CUHK Launches Newborn Add-on Test for Congenital Adrenal Hyperplasia Supported by Joshua Hellmann Foundation for Orphan Disease

Donation
CUHK Reveals Hepatitis B Prevalence Among Pregnant Women Remains High Despite More Than 25 Years of Universal Hepatitis B Vaccination

CUHK Reveals Hepatitis B Prevalence Among Pregnant Women Remains High Despite More Than 25 Years of Universal Hepatitis B Vaccination

Research
CUHK Reveals Vasopressin Injection Can Reduce Risks of Hysteroscopic Myomectomy

CUHK Reveals Vasopressin Injection Can Reduce Risks of Hysteroscopic Myomectomy

Research
CUHK and Joshua Hellmann Foundation for Orphan Disease Jointly Launch Territory’s First Newborn Metabolic Screening Program

CUHK and Joshua Hellmann Foundation for Orphan Disease Jointly Launch Territory’s First Newborn Metabolic Screening Program

Donation
CUHK and US Experts Collaborate to Provide Clinical Genetic Training to Set up The Territory's First One-Stop Outpatient Genetic Clinic

CUHK and US Experts Collaborate to Provide Clinical Genetic Training to Set up The Territory's First One-Stop Outpatient Genetic Clinic

International collaboration
CUHK Pioneers DNA Chip for Prenatal Diagnosis in HK

CUHK Pioneers DNA Chip for Prenatal Diagnosis in HK

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.